Published May 29, 2026 | Reporting by Ben Fidler The biopharmaceutical landscape continues to demonstrate the high-stakes...
Chemotherapy and Targeted Therapy
In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent a...
By Delilah Alvarado Published May 26, 2026 In a strategic maneuver that marks a significant diversification of...
In the rapidly evolving landscape of metabolic medicine, Eli Lilly’s experimental drug, retatrutide, has emerged as a...
The high-stakes battle for dominance in the burgeoning obesity medication market has reached a new inflection point....
In a landmark development for regenerative medicine, Cellular Intelligence—a high-profile startup formerly known as Somite AI—has secured...
In the high-stakes arena of immunology and dermatology, Apogee Therapeutics is making a compelling case for a...
In a move that signals a renewed appetite for late-stage biotechnology offerings, Kardigan, a cardiovascular-focused startup founded...
The biotechnology sector is experiencing a profound renaissance. Following a period of economic recalibration, the industry is...
In a major shift that signals both the growing pains of artificial intelligence in medicine and a...
